US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist
  • 291.160
  • -3.430-1.16%
Close Feb 14 16:00 ET
  • 289.510
  • -1.650-0.57%
Pre 05:27 ET
156.41BMarket Cap38.51P/E (TTM)

About Amgen Company

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Company Profile

SymbolAMGN
Company NameAmgen
Listing DateJun 1, 1983
Issue Price18.00
Founded1980
CEOMr. Robert A. Bradway
MarketNASDAQ
Employees28000
Fiscal Year Ends12-31
AddressOne Amgen Center Drive
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320-1799
Phone1-805-447-1000
Websitehttp://www.amgen.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert A. Bradway
  • Chairman of the Board, President and Chief Executive Officer
  • 22.64M
  • Nancy A. Grygiel
  • Senior Vice President and Chief Compliance Officer
  • --
  • Peter H. Griffith
  • Executive Vice President and Chief Financial Officer
  • 6.02M
  • Dr. David M. Reese, M.D.
  • Executive Vice President and Chief Technology Officer
  • 7.90M
  • Matthew C. Busch
  • Vice President, Finance and Chief Accounting Officer
  • --
  • Dr. James E. Bradner, M.D.
  • Executive Vice President, Research and Development
  • --
  • Esteban Santos
  • Executive Vice President, Operations
  • 7.21M
  • Murdo Gordon
  • Executive Vice President, Global Commercial Operations
  • 8.24M
  • Derek Miller
  • Senior Vice President, Human Resources
  • --
  • Rachna Khosla
  • Senior Vice President, Business Development
  • --
  • Jonathan P. Graham
  • Executive Vice President, General Counsel and Secretary
  • --
  • Dr. Brian J. Druker, M.D.
  • Independent Director
  • 359.92K
  • Robert A. Eckert
  • Lead Independent Director
  • 419.92K
  • Professor Dr. Tyler E. Jacks, PhD
  • Independent Director
  • 339.92K
  • Dr. Wanda M. Austin
  • Independent Director
  • 359.92K
  • Greg C. Garland
  • Independent Director
  • 379.92K
  • Mary E. Klotman
  • Independent Director
  • --
  • Michael V. Drake
  • Independent Director
  • 339.92K
  • Dr. S. Omar Ishrak
  • Independent Director
  • 366.47K
  • Ellen J. Kullman
  • Independent Director
  • 360.29K
  • Amy E. Miles
  • Independent Director
  • 359.92K
  • Charles M. Holley, Jr
  • Independent Director
  • 369.92K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.